SGRY Valuation

Surgery Partners Inc

Add to Watchlist

Advanced Chart

21.500

-0.11(-0.509%)1D

SGRY Relative Valuation

SGRY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SGRY is overvalued; if below, it's undervalued.

Historical Valuation

Surgery Partners Inc (SGRY) is now in the Fair zone, suggesting that its current forward PS ratio of 21.50 is considered Fairly compared with the five-year average of -332.52. The fair price of Surgery Partners Inc (SGRY) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：21.50

Fair

23.70

Trailing

Forward

14.04

EV/EBITDA

Surgery Partners Inc. (SGRY) has a current EV/EBITDA of 14.04. The 5-year average EV/EBITDA is 18.19. The thresholds are as follows: Strongly Undervalued below 11.18, Undervalued between 11.18 and 14.68, Fairly Valued between 21.69 and 14.68, Overvalued between 21.69 and 25.19, and Strongly Overvalued above 25.19. The current Forward EV/EBITDA of 14.04 falls within the Undervalued range.

17.98

EV/EBIT

Surgery Partners Inc. (SGRY) has a current EV/EBIT of 17.98. The 5-year average EV/EBIT is 19.95. The thresholds are as follows: Strongly Undervalued below 15.04, Undervalued between 15.04 and 17.50, Fairly Valued between 22.40 and 17.50, Overvalued between 22.40 and 24.86, and Strongly Overvalued above 24.86. The current Forward EV/EBIT of 17.98 falls within the Historic Trend Line -Fairly Valued range.

21.50

Surgery Partners Inc. (SGRY) has a current PS of 21.50. The 5-year average PS is 1.39. The thresholds are as follows: Strongly Undervalued below -2.00, Undervalued between -2.00 and -0.31, Fairly Valued between 3.08 and -0.31, Overvalued between 3.08 and 4.78, and Strongly Overvalued above 4.78. The current Forward PS of 21.50 falls within the Strongly Overvalued range.

7.39

P/OCF

Surgery Partners Inc. (SGRY) has a current P/OCF of 7.39. The 5-year average P/OCF is -170.61. The thresholds are as follows: Strongly Undervalued below -1862.14, Undervalued between -1862.14 and -1016.38, Fairly Valued between 675.15 and -1016.38, Overvalued between 675.15 and 1520.91, and Strongly Overvalued above 1520.91. The current Forward P/OCF of 7.39 falls within the Historic Trend Line -Fairly Valued range.

10.17

P/FCF

Surgery Partners Inc. (SGRY) has a current P/FCF of 10.17. The 5-year average P/FCF is 5.15. The thresholds are as follows: Strongly Undervalued below -171.54, Undervalued between -171.54 and -83.19, Fairly Valued between 93.50 and -83.19, Overvalued between 93.50 and 181.85, and Strongly Overvalued above 181.85. The current Forward P/FCF of 10.17 falls within the Historic Trend Line -Fairly Valued range.

Surgery Partners Inc (SGRY) has a current Price-to-Book (P/B) ratio of 1.57. Compared to its 3-year average P/B ratio of 1.87 , the current P/B ratio is approximately -16.46% higher. Relative to its 5-year average P/B ratio of 3.80, the current P/B ratio is about -58.85% higher. Surgery Partners Inc (SGRY) has a Forward Free Cash Flow (FCF) yield of approximately 6.40%. Compared to its 3-year average FCF yield of 4.46%, the current FCF yield is approximately 43.57% lower. Relative to its 5-year average FCF yield of 4.39% , the current FCF yield is about 45.90% lower.

1.57

P/B

Median3y

1.87

Median5y

3.80

6.40

FCF Yield

Median3y

4.46

Median5y

4.39

Competitors Valuation Multiple

The average P/S ratio for SGRY's competitors is 35.50, providing a benchmark for relative valuation. Surgery Partners Inc Corp (SGRY) exhibits a P/S ratio of 21.50, which is -39.43% above the industry average. Given its robust revenue growth of 8.41%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Brookdale Senior Living Inc

National Healthcare Corp

127.17

24.70%

1.97B

Performance Decomposition

Market capitalization of SGRY decreased by 9.82% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 3.73 to 5.43.

The secondary factor is the Revenue Growth, contributed 8.41%to the performance.

Overall, the performance of SGRY in the past 1 year is driven by Margin Expansion. Which is more sustainable.

8.41%

762.10M → 826.20M

Revenue Growth

45.58%

3.73 → 5.43

Margin Expansion

-63.81%

-41.61 → -15.06

P/E Change

-9.82%